Visual Outcomes in Pediatric Optic Pathway Glioma After Conformal Radiation Therapy

被引:37
作者
Awdeh, Richard M. [1 ]
Kiehna, Erin N. [1 ]
Drewry, Richard D. [3 ]
Kerr, Natalie C. [3 ]
Haik, Barrett G. [3 ]
Wu, Shengjie [2 ]
Xiong, Xiaoping [2 ]
Merchant, Thomas E. [1 ]
机构
[1] St Jude Childrens Res Hosp, Div Radiat Oncol, Memphis, TN 38105 USA
[2] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA
[3] Univ Tennessee, Dept Ophthalmol, Memphis, TN USA
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2012年 / 84卷 / 01期
关键词
Vision; Pediatrics; Glioma; Radiotherapy; TERM-FOLLOW-UP; HYPOTHALAMIC GLIOMAS; CHILDREN; TUMORS; CHEMOTHERAPY; MANAGEMENT; ACUITY; CHILDHOOD; SURVIVAL; AGE;
D O I
10.1016/j.ijrobp.2011.10.067
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To assess visual outcome prospectively after conformal radiation therapy (CRT) in children with optic pathway glioma. Methods and Materials: We used CRT to treat optic pathway glioma in 20 children (median age 9.3 years) between July 1997 and January 2002. We assessed changes in visual acuity using the logarithm of the minimal angle of resolution after CRT (54 Gy) with a median follow-up of 24 months. We included in the study children who underwent chemotherapy (8 patients) or resection (9 patients) before CRT. Results: Surgery played a major role in determining baseline (pre-CRT) visual acuity (better eye: P = .0431; worse eye: P = .0032). The visual acuity in the worse eye was diminished at baseline (borderline significant) with administration of chemotherapy before CRT (P = .0726) and progression of disease prior to receiving CRT (P = .0220). In the worse eye, improvement in visual acuity was observed in patients who did not receive chemotherapy before CRT (P = .0289). Conclusions: Children with optic pathway glioma initially treated with chemotherapy prior to receiving radiation therapy have decreased visual acuity compared with those who receive primary radiation therapy. Limited surgery before radiation therapy may have a role in preserving visual acuity. (C) 2012 Elsevier Inc.
引用
收藏
页码:46 / 51
页数:6
相关论文
共 33 条
[1]  
[Anonymous], 1999, SAS STAT US GUID VER
[2]   Long term follow up of 69 patients treated for optic pathway tumours before the chemotherapy era [J].
Cappelli, C ;
Grill, J ;
Raquin, M ;
Pierre-Kahn, A ;
Lellouch-Tubiana, A ;
Terrier-Lacombe, MJ ;
Habrand, JL ;
Couanet, D ;
Brauner, R ;
Rodriguez, D ;
Hartmann, O ;
Kalifa, C .
ARCHIVES OF DISEASE IN CHILDHOOD, 1998, 79 (04) :334-338
[3]   Endocrine outcome in long-term survivors of low-grade hypothalamic/chiasmatic glioma [J].
CollettSolberg, PF ;
Sernyak, H ;
SatinSmith, M ;
Katz, LL ;
Sutton, L ;
Molloy, P ;
Moshang, T .
CLINICAL ENDOCRINOLOGY, 1997, 47 (01) :79-85
[4]   RADIOTHERAPEUTIC MANAGEMENT OF OPTIC-NERVE GLIOMAS IN CHILDREN [J].
DANOFF, BF ;
KRAMER, S ;
THOMPSON, N .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1980, 6 (01) :45-50
[5]   Relapses of Optic Pathway Tumors After First-Line Chemotherapy [J].
de Haas, Valerie ;
Grill, Jacques ;
Raquin, Marie-Anne ;
Couanet, Dominique ;
Habrand, Jean-Louis ;
Sainte-Rose, Christian ;
Laithier, Veronique ;
Kieffer, Virginie ;
Kalifa, Chantal .
PEDIATRIC BLOOD & CANCER, 2009, 52 (05) :575-580
[6]   Fractionated stereotactic radiotherapy (FSRT) for optic glioma [J].
Debus, J ;
Kocagöncü, KO ;
Höss, A ;
Wenz, F ;
Wannenmacher, M .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 44 (02) :243-248
[7]  
EPSTEIN MA, 1992, CANCER, V70, P887
[8]   Management of optic pathway and chiasmatic-hypothalamic gliomas in children with radiation therapy [J].
Erkal, HS ;
Serin, M ;
Cakmak, A .
RADIOTHERAPY AND ONCOLOGY, 1997, 45 (01) :11-15
[9]   Long-term visual outcome in patients with anterior visual pathway gliomas [J].
Gayre, GS ;
Scott, IU ;
Feuer, W ;
Saunders, TG ;
Siatkowski, RM .
JOURNAL OF NEURO-OPHTHALMOLOGY, 2001, 21 (01) :1-7
[10]   Radiation therapy of optico-hypothalamic gliomas (OHG) -: radiographic response, vision and late toxicity [J].
Grabenbauer, GG ;
Schuchardt, U ;
Buchfelder, M ;
Rödel, CM ;
Gusek, G ;
Marx, M ;
Doerr, HG ;
Fahlbusch, R ;
Huk, WJ ;
Wenzel, D ;
Sauer, R .
RADIOTHERAPY AND ONCOLOGY, 2000, 54 (03) :239-245